TNFSF10 and breast cancer: Analyses in breast cancer cell lines have shown that triple-negative cells (i.e., ER–/PR–/HER2–) are especially sensitive to TRAIL-induced apoptosis, whereas sensitivity to TRAIL varies across different HER2+ cell lines, and is systematically absent among ER+ cells [7].